Ligand Pharmaceuticals
LGND
#3042
Rank
C$7.77 B
Marketcap
C$389.91
Share price
-1.42%
Change (1 day)
77.47%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2026 (TTM): C$0.26 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are C$0.27 Billion. In 2025 the company made an earning of C$0.22 Billion, an increase over its 2024 earnings that were of C$7.71 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.26 B15.82%
2025 C$0.22 B2848.57%
2024 C$7.71 M-91.37%
2023 C$89.4 M-7.59%
2022 C$96.75 M4%
2021 C$93.02 M296.42%
2020 C$23.46 M-97.97%
2019 C$1.15 B275.62%
2018 C$0.30 B237.48%
2017 C$91.27 M49.05%
2016 C$61.24 M55.41%
2015 C$39.4 M36.87%
2014 C$28.79 M29.59%
2013 C$22.21 M1309.35%
2012 C$1.57 M-43.97%
2011 C$2.81 M-113.19%
2010 -C$21.34 Million59.86%
2009 -C$13.35 Million-61.33%
2008 -C$34.51 Million-58.75%
2007 -C$83.65 Million20.52%
2006 -C$69.41 Million81.27%
2005 -C$38.3 Million
2003 -C$26.66 Million-20.6%
2002 -C$33.58 Million4.38%
2001 -C$32.17 Million-48.83%
2000 -C$62.86 Million-19.74%
1999 -C$78.32 Million-19.06%
1998 -C$96.76 Million126.71%
1997 -C$42.68 Million-5.83%
1996 -C$45.32 Million136.23%
1995 -C$19.19 Million-33.97%
1994 -C$29.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.11 B 13,538.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.72 B 5,460.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$43.26 B 16,240.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.63 B 4,670.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-C$0.71 Billion-366.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.28 B 6,804.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.34 B 4,938.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$13.91 B 5,155.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-C$86.03 Million-132.49%๐Ÿ‡บ๐Ÿ‡ธ USA